Joachim G J V Aerts

29PUBLICATIONS
240CO-AUTHORS
Tumour immunologyNatural language processingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 10, 2026
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.

|Sep 01, 2026
Impact of Commercial Artificial Intelligence on Radiologist Reading Time for Pulmonary Nodule Evaluation at Chest CT.

|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|Jun 24, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study.

|May 06, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC after Immune Checkpoint Blockade.

|Nov 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.

Songul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg

Pageof 5

Frequent Collaborators

6 joint publications

Merel E Hellemons

4 joint publications

Ralph Stadhouders

3 joint publications

Joanne M Mankor

3 joint publications

Harry J M Groen